Longitude Capital Partners II, LLC sold RPID

January 23, 2026 · Form 4 insider transaction

Longitude Capital Partners II, LLC sold 7,739 shares of Rapid Micro Biosystems, Inc. at $4.06 per share, a transaction worth $31.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 11 days after the transaction.

Direction
Disposed (sell-side)
Shares
7,739
Price
$4.06
Total value
$31.5K
Role10% owner
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 23, 2026
Filing dateFebruary 3, 2026
Shares owned after4,029,245
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Longitude Venture Partners II, L.P. ("LVPII") exercised warrants to purchase an aggregate of 629,032 shares of the Issuer's Class A common stock for $0.05 per share and paid the exercise price on a cashless basis, resulting in the Issuer withholding 7,739 shares of the Issuer's shares of Class A common stock subject to the warrant to pay the exercise price.; The securities are held directly by LVPII. Longitude Capital Partners II, LLC, ("LCPII"), the general partner of LVPII, may be deemed to have voting and dispositive power with respect to the shares held by LVPII. Patrick G. Enright and Juliet Tammenoms Bakker are the managing members of LCPII and may be deemed to share voting and dispositive power over the shares held by LVPII. Each of LCPII, Mr. Enright and Ms. Tammenoms Bakker disclaim beneficial ownership of such securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interest therein.

View the original Form 4 on SEC EDGAR